|
Originally published In Press as doi:10.1074/jbc.M507192200 on September 13, 2005
J. Biol. Chem., Vol. 280, Issue 48, 40084-40096, December 2, 2005
Endogenous Thioredoxin Is Required for Redox Cycling of Anthracyclines and p53-dependent Apoptosis in Cancer Cells*
Dashnamoorthy Ravi,
Harish Muniyappa, and
Kumuda C. Das1
From the
Department of Pathology and Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Apoptosis is a major mechanism of cancer cell destruction by chemotherapy and radiotherapy. The anthracycline class of antitumor drugs undergoes redox cycling in living cells producing increased amounts of reactive oxygen species and semiquinone radical, both of which can cause DNA damage, and consequently trigger apoptotic death of cancer cells. We show here that MCF-7 cells overexpressing thioredoxin (Trx) were more apoptotic in response to daunomycin. Trx overexpression in MCF-7 cells increased the generation of superoxide anion ( ) in anthracycline-treated cell extracts. Enhanced generation of in response to daunomycin inTrx-overexpressing MCF-7 cells was inhibited by diphenyleneiodonium chloride, a general NADPH reductase inhibitor, demonstrating that Trx provides reducing equivalents to a bioreductive enzyme for redox cycling of daunomycin. Additionally Trx increased p53-DNA binding and expression in response to anthracyclines. MCF-7 cells expressing mutant redox-inactive Trx showed decreased superoxide generation, apoptosis, and p53 protein and DNA binding. In addition, down-regulation of endogenous Trx expression by small interfering RNA resulted in decreased expression of caspase-7 and cleaved poly(ADP-ribose) polymerase expression in response to daunomycin. These results suggest that endogenous Trx is required for anthracycline-mediated apoptosis of breast cancer cells. Taken together, our data demonstrate a novel pro-oxidant and proapoptotic role of Trx in anthracycline-mediated apoptosis in anthracycline chemotherapy.
Received for publication, July 1, 2005
, and in revised form, September 12, 2005.
* This work was supported in part by a research project grant from the American Cancer Society (to K. C. D.) and National Institutes of Health Grant 1R01HL 071558 (to K. C. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 845, Little Rock, AR 72205. Tel.: 501-526-4597; Fax: 501-526-4601; E-mail: kdas{at}uams.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Muniyappa, S. Song, C. K. Mathews, and K. C. Das
Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia: INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL
J. Biol. Chem.,
June 19, 2009;
284(25):
17069 - 17081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Park, Y. J. Jung, J. R. Lee, Y. M. Lee, H. H. Jang, S. S. Lee, J. H. Park, S. Y. Kim, J. C. Moon, S. Y. Lee, et al.
Heat-Shock and Redox-Dependent Functional Switching of an h-Type Arabidopsis Thioredoxin from a Disulfide Reductase to a Molecular Chaperone
Plant Physiology,
June 1, 2009;
150(2):
552 - 561.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|